Pharmacogenetics of lipid diseases
<p>Abstract</p> <p>The genetic basis for most of the rare lipid monogenic disorders have been elucidated, but the challenge remains in determining the combination of genes that contribute to the genetic variability in lipid levels in the general population; this has been estimated...
Main Author: | Ordovas Jose M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2004-01-01
|
Series: | Human Genomics |
Subjects: | |
Online Access: | http://www.humgenomics.com/content/1/2/111 |
Similar Items
-
From intensive statins to intensive lipid lowering: Amplitude of low-density lipoprotein-cholesterol lowering is the core for atherosclerosis cardiovascular disease prevention
by: Daoquan Peng
Published: (2018-01-01) -
Lipid treatment and goal attainment characteristics among persons with atherosclerotic cardiovascular disease in the United States
by: Alexa C. Klimchak, et al.
Published: (2020-03-01) -
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
by: Claes Bergmark, et al.
Published: (2008-10-01) -
Gene therapy for lipid disorders
by: Rader Daniel J, et al.
Published: (2000-10-01) -
Hypocholesterolemic Effect of Blackcurrant (<i>Ribes nigrum</i>) Extract in Healthy Female Subjects: A Pilot Study
by: Naoki Nanashima, et al.
Published: (2021-07-01)